Ally Bridge Group (ABG) is a global healthcare investment firm focused on high-impact life sciences innovation. Since its founding in 2013, the firm has been the lead or co-lead investor in transactions totaling >$6B across healthcare sub-sectors. ABG's mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. The firm aims to achieve this by blending deep scientific domain knowledge with proven M&A and capital markets expertise.

Re-launched the "MedAlpha Fund", a long-biased hedge fund investing in commercial- and development-stage SMid-cap life sciences companies within the pharmaceutical / biotechnology, medical technology / devices, and diagnostics / tools sub-sectors.

Championed strategy development, network / logistics formation, expansion initiatives, coverage / diligence workstreams, and portfolio management for investments within the public SMid-cap and private life sciences sector for a recently launched healthcare-focused hedge fund

Spearheaded idea generation and diligence of commercial- and development-stage public SMid-cap biotech investments for a life sciences-focused hedge fund

‣ Transitioned with team from Credit Suisse to initiate coverage of large- & SMid-cap biotech companies‣ Coverage universe: ABEO, AGIO, AIMT, AKBA, ALXN, AMGN, ANAB, ARNA, ATNX, BIVV, BMRN, CLVS, EXEL, FPRX, IMGN, OBSV, ONCE, PBYI, PRTA, RARX, REGN, SGEN, TSRO, and XLRN

‣ Provided coverage of the SMid-cap biotech sector for the institutional investor community‣ Coverage universe: AGIO, AKBA, ANAB, BMRN, CLVS, ECYT, FGEN, FPRX, INCY, MDVN, OVAS, OBSV, PBYI, PRTA, RARE, RARX, RXDX, SGEN, and XLRN

Bionest Partners is a global strategy consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Project experience includes: ‣ Business development strategy (corporate, franchise, single asset) ‣ Market opportunity assessment (general medicine & specialty diseases)‣ New product / portfolio planning (clinical development strategy, life cycle management) ‣ Commercial strategy (brand & franchise)

AgencyRx is a full-service healthcare communications agency that supports global brands with strategic and promotional capabilities from pre-launch commercialization to loss of exclusivity. The Business Strategy group uncovers insights that elucidate opportunities or challenges to maximize product potential. Using various marketing tools, the team uncovers business building initiatives that can improve performance across the full life cycle of a product.